SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

EQL Pharma Schedules Presentation for Second-Quarter 2026/27 Report

EQL Pharma AB says it will publish its interim report for the second quarter of 2026/27; the headline announces a related presentation invitation.

Related stories